Table III.
Multivariate logistic regression analysis of factors that may affect the expression of LDHD and LDHAL6B in The Cancer Genome Atlas cohort with clear cell renal cell carcinoma.
| LDHD | LDHAL6B | |||||
|---|---|---|---|---|---|---|
| Variables | OR | (95% CI) | P-value | OR | (95% CI) | P-value |
| Age | 1.013 | (0.987–1.040) | 0.314 | 1.0114 | (0.986–1.038) | 0.382 |
| T | 0.565 | (0.389–0.819) | 0.003 | 1.0560 | (0.734–1.520) | 0.771 |
| N | 0.965 | (0.255–3.650) | 0.958 | 0.7600 | (0.216–2.671) | 0.669 |
| M | 1.652 | (0.695–3.926) | 0.256 | 0.6730 | (0.286–1.581) | 0.363 |
| Fuhrman grade | 0.788 | (0.499–1.243) | 0.305 | 1.0480 | (0.665–1.649) | 0.841 |
| Hb | 1.320 | (0.700–2.488) | 0.391 | 0.3800 | (0.202–0.717) | 0.003 |
| WBC | 1.048 | (0.564–1.948) | 0.881 | 0.6880 | (0.371–1.276) | 0.236 |
| PLT | 1.065 | (0.564–2.011) | 0.847 | 1.4330 | (0.756–2.718) | 0.271 |
LDH, lactate dehydrogenase; LDHAL6B, LDH A like 6B; OR, odds ratio; CI, confidence interval; T, tumor; N, node; M, metastasis; Hb, hemoglobin; WBC, white blood cell; PLT, platelet.